Presentations & Publications
// May 12, 2026 | Poster
American Society of Gene and Cell Therapy (ASGCT)
Versatile and robust epigenetic modulation platform for programmable gene activation and repression
// May 12, 2026 | Poster
American Society of Gene and Cell Therapy (ASGCT)
Leveraging protein and gRNA engineering of diverse CRISPR systems to optimize adenosine base editor activity for correction of a causative monogenic disease mutation
// May 06, 2026 | Poster
International Society for Cell & Gene Therapy (ISCT)
A Novel Non-Viral Platform Combining a LEG Nuclease and mbDNA for High-Efficiency T-Cell Engineering
// Apr 30, 2026 | Presentation
2026 Outsourced Pharma
Engineering Precision In Genetic Medicines
// Apr 13, 2026 | Presentation
The 3rd CRISPR MEDiCiNE Conference
Optimizing gene knockdown and in vivo base editing with novel CRISPR systems
// Mar 05, 2026 | Panel
Endpoints Cell & Gene Day
Manufacturing, testing and technology innovation for rapid cell therapy
// Feb 10, 2026 | Interview
Advanced Therapies Week 2026
Strategic Foundation: Why Commercial Ready Manufacturing Should Be Considered from Day One
// Feb 10, 2026 | Presentation
Advanced Therapies Week 2026
Reducing Turnaround Time and Cost in Cell Therapy Manufacturing Through Integrated At-Line Immunophenotyping QC
// Feb 10, 2026 | Presentation
Advanced Therapies Week 2026
Automating Cell Therapy: A Closed, Digital Platform Delivers Consistent, Sterile, Scalable T‑Cell Production
// Feb 10, 2026 | Presentation
Advanced Therapies Week 2026
Evaluating the Automated Accellix® Platform against Conventional Flow Cytometry for Cell Therapy Samples
// Feb 10, 2026 | Presentation
Advanced Therapies Week 2026
Supporting Therapy Platform Development with Advanced Characterization of Engineered T Cells via Single-cell Sequencing and Flow Cytometry
// Feb 07, 2026 | Presentation
Society for Laboratory Automation and Screening Conference 2026
